Cargando…

Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer

BACKGROUND: Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggen, Annemarie C, Richard, Nadine M, Bosma, Ingeborg, Jalving, Mathilde, Leighl, Natasha B, Liu, Geoffrey, Mah, Kenneth, Higazy, Randa, Shultz, David B, Reyners, Anna K L, Rodin, Gary, Edelstein, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789294/
https://www.ncbi.nlm.nih.gov/pubmed/35087675
http://dx.doi.org/10.1093/nop/npab056
_version_ 1784639735519510528
author Eggen, Annemarie C
Richard, Nadine M
Bosma, Ingeborg
Jalving, Mathilde
Leighl, Natasha B
Liu, Geoffrey
Mah, Kenneth
Higazy, Randa
Shultz, David B
Reyners, Anna K L
Rodin, Gary
Edelstein, Kim
author_facet Eggen, Annemarie C
Richard, Nadine M
Bosma, Ingeborg
Jalving, Mathilde
Leighl, Natasha B
Liu, Geoffrey
Mah, Kenneth
Higazy, Randa
Shultz, David B
Reyners, Anna K L
Rodin, Gary
Edelstein, Kim
author_sort Eggen, Annemarie C
collection PubMed
description BACKGROUND: Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strategies for these difficulties. We aimed to identify the frequency of cognitive problems and associated factors in patients with mNSCLC. METHODS: In this cross-sectional study, adults with mNSCLC completed validated neuropsychological tests and self-report questionnaires measuring cognitive concerns, neurobehavioral concerns, depression, demoralization, illness intrusiveness, self-esteem, and physical symptoms. Cognitive impairment (performance based) was defined according to International Cancer and Cognition Task Force criteria. Clinically significant cognitive concerns were defined by a score ≥1.5 SD below the normative mean on the Functional Assessment of Cancer Therapy-Cognitive Function Perceived Cognitive Impairment (FACT-Cog PCI). Univariate and multivariate logistic regression analyses were performed to identify associated factors. RESULTS: Of 238 patients approached, 77 participated (median age: 62 years; range: 37-82). Brain metastases were present in 41 patients (53%), and 23 (29%) received cranial irradiation. Cognitive impairment and cognitive concerns were present in 31 (40%) and 20 patients (26%), respectively. Cognitive impairment and cognitive concerns co-occurred in 10 patients (13%), but their severity was unrelated. Cognitive impairment was associated with cranial irradiation (odds ratio [OR] = 2.89; P = .04), whereas cognitive concerns were associated with greater illness intrusiveness (OR = 1.04; P = .03) and lower self-esteem (OR = 0.86; P = .03). CONCLUSIONS: Cognitive impairment and cognitive concerns are both common in patients with mNSCLC but are not necessarily related, and their risk factors differ. The association of illness intrusiveness and self-esteem with cognitive concerns can inform therapeutic interventions in this population.
format Online
Article
Text
id pubmed-8789294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-87892942022-01-26 Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer Eggen, Annemarie C Richard, Nadine M Bosma, Ingeborg Jalving, Mathilde Leighl, Natasha B Liu, Geoffrey Mah, Kenneth Higazy, Randa Shultz, David B Reyners, Anna K L Rodin, Gary Edelstein, Kim Neurooncol Pract Original Articles BACKGROUND: Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strategies for these difficulties. We aimed to identify the frequency of cognitive problems and associated factors in patients with mNSCLC. METHODS: In this cross-sectional study, adults with mNSCLC completed validated neuropsychological tests and self-report questionnaires measuring cognitive concerns, neurobehavioral concerns, depression, demoralization, illness intrusiveness, self-esteem, and physical symptoms. Cognitive impairment (performance based) was defined according to International Cancer and Cognition Task Force criteria. Clinically significant cognitive concerns were defined by a score ≥1.5 SD below the normative mean on the Functional Assessment of Cancer Therapy-Cognitive Function Perceived Cognitive Impairment (FACT-Cog PCI). Univariate and multivariate logistic regression analyses were performed to identify associated factors. RESULTS: Of 238 patients approached, 77 participated (median age: 62 years; range: 37-82). Brain metastases were present in 41 patients (53%), and 23 (29%) received cranial irradiation. Cognitive impairment and cognitive concerns were present in 31 (40%) and 20 patients (26%), respectively. Cognitive impairment and cognitive concerns co-occurred in 10 patients (13%), but their severity was unrelated. Cognitive impairment was associated with cranial irradiation (odds ratio [OR] = 2.89; P = .04), whereas cognitive concerns were associated with greater illness intrusiveness (OR = 1.04; P = .03) and lower self-esteem (OR = 0.86; P = .03). CONCLUSIONS: Cognitive impairment and cognitive concerns are both common in patients with mNSCLC but are not necessarily related, and their risk factors differ. The association of illness intrusiveness and self-esteem with cognitive concerns can inform therapeutic interventions in this population. Oxford University Press 2021-09-07 /pmc/articles/PMC8789294/ /pubmed/35087675 http://dx.doi.org/10.1093/nop/npab056 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Eggen, Annemarie C
Richard, Nadine M
Bosma, Ingeborg
Jalving, Mathilde
Leighl, Natasha B
Liu, Geoffrey
Mah, Kenneth
Higazy, Randa
Shultz, David B
Reyners, Anna K L
Rodin, Gary
Edelstein, Kim
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
title Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
title_full Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
title_fullStr Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
title_full_unstemmed Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
title_short Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
title_sort factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789294/
https://www.ncbi.nlm.nih.gov/pubmed/35087675
http://dx.doi.org/10.1093/nop/npab056
work_keys_str_mv AT eggenannemariec factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT richardnadinem factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT bosmaingeborg factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT jalvingmathilde factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT leighlnatashab factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT liugeoffrey factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT mahkenneth factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT higazyranda factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT shultzdavidb factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT reynersannakl factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT rodingary factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer
AT edelsteinkim factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer